See also this year's filing and all EDGAR filings for this company.
PDF Report 0001540159_2019_Edesa_Biotech_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 211849, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001540159, Edesa Biotech Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 10,655,984 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,062,195 |
| 3 | remainder_Assets | 61,796 |
| 4 | LiabilitiesCurrent | 493,385 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 120,831 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,729,830 |
| 9 | ResearchAndDevelopmentExpense | 2,048,233 |
| 10 | remainder_Expenses | 303,901 |
| 11 | remainder_Revenues | 213,441 |
| 12 | remainder_NetIncome | 111,303 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,779,975 |
| 1 | Liabilities | 493,385 |
| 2 | Expenses | 5,202,795 |
| 3 | Revenues | 213,441 |
| 4 | StockholdersEquity | 11,286,590 |
| 5 | NetIncome | -4,878,051 |
| 6 | ComprehensiveNetIncome | -4,878,051 |
| 7 | BaseVar | 8,900,450 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.21 |
| 9 | EconomicCapitalRatio | 3.83 |
Edgar->Model Mapping
Feature Distribution
Change over Time
